Simplex Trading’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,946
| Closed | -$154K | – | 8750 |
|
|
2025
Q1 | $194K | Buy |
12,946
+12,587
| +3,506% | +$211K | ﹤0.01% | 4355 |
|
|
2024
Q4 | $6K | Buy |
+359
| New | +$6.93K | ﹤0.01% | 7485 |
|
|
2024
Q2 | – | Sell |
-1,039
| Closed | -$18.4K | – | 8892 |
|
|
2024
Q1 | $17K | Sell |
1,039
-7,795
| -88% | -$123K | ﹤0.01% | 7209 |
|
|
2023
Q4 | $156K | Buy |
8,834
+3,221
| +57% | +$64.9K | ﹤0.01% | 4924 |
|
|
2023
Q3 | $134K | Buy |
+5,613
| New | +$138K | ﹤0.01% | 4794 |
|
|
2023
Q2 | – | Sell |
-4,729
| Closed | -$107K | – | 9062 |
|
|
2023
Q1 | $104K | Buy |
4,729
+2,717
| +135% | +$63.6K | ﹤0.01% | 5106 |
|
|
2022
Q4 | $40K | Sell |
2,012
-7,678
| -79% | -$149K | ﹤0.01% | 6141 |
|
|
2022
Q3 | $130K | Buy |
9,690
+4,531
| +88% | +$76.4K | ﹤0.01% | 5171 |
|
|
2022
Q2 | $102K | Sell |
5,159
-7,972
| -61% | -$212K | ﹤0.01% | 5539 |
|
|
2022
Q1 | $415K | Buy |
+13,131
| New | +$368K | ﹤0.01% | 4081 |
|
|
2021
Q4 | – | Sell |
-2,589
| Closed | -$67.5K | – | 10545 |
|
|
2021
Q3 | $101K | Sell |
2,589
-506
| -16% | -$15.4K | ﹤0.01% | 6607 |
|
|
2021
Q2 | $120K | Buy |
+3,095
| New | +$111K | ﹤0.01% | 6462 |
|
|
2020
Q3 | – | Sell |
-8,733
| Closed | -$183K | – | 7844 |
|
|
2020
Q2 | $177K | Buy |
8,733
+8,616
| +7,364% | +$154K | ﹤0.01% | 4127 |
|
|
2020
Q1 | $1K | Buy |
+117
| New | +$3.27K | ﹤0.01% | 7329 |
|
|
2019
Q4 | – | Sell |
-19,857
| Closed | -$892K | – | 7351 |
|
|
2019
Q3 | $925K | Buy |
19,857
+12,303
| +163% | +$572K | ﹤0.01% | 2002 |
|
|
2019
Q2 | $394K | Buy |
7,554
+5,132
| +212% | +$301K | ﹤0.01% | 2809 |
|
|
2019
Q1 | $166K | Sell |
2,422
-435
| -15% | -$29.2K | ﹤0.01% | 3800 |
|
|
2018
Q4 | $170K | Buy |
+2,857
| New | +$247K | ﹤0.01% | 3324 |
|
|
2018
Q2 | – | Sell |
-1,053
| Closed | -$128K | – | 7398 |
|
|
2018
Q1 | $113K | Buy |
+1,053
| New | +$117K | 0.01% | 1712 |
|
|
2017
Q1 | – | Sell |
-458
| Closed | -$53.2K | – | 6195 |
|
|
2016
Q4 | $54K | Buy |
458
+19
| +4% | +$2.1K | ﹤0.01% | 2078 |
|
|
2016
Q3 | $49K | Buy |
+439
| New | +$50.6K | ﹤0.01% | 2124 |
|
|
2015
Q4 | – | Sell |
-6,476
| Closed | -$741K | – | 5453 |
|
|
2015
Q3 | $646K | Buy |
6,476
+4,300
| +198% | +$468K | 0.05% | 356 |
|
|
2015
Q2 | $248K | Buy |
2,176
+224
| +11% | +$27.2K | 0.02% | 694 |
|
|
2015
Q1 | $203K | Buy |
+1,952
| New | +$208K | 0.02% | 714 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Simplex Trading's CLB Position: Q2 2025 in Review
Simplex Trading sold out of Core Laboratories (CLB) in Q2 2025, closing a stake of 12,946 shares — an estimated $154K sold.
Simplex Trading first reported a position in CLB in Q1 2015 and held it in 24 quarters. The position peaked at $925K in Q3 2019. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.
- Simplex Trading reported no remaining Core Laboratories position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 12,946 Core Laboratories shares in Q2 2025, an estimated $154K.
- Simplex Trading first reported a position in Core Laboratories in Q1 2015 and held it in 24 quarters.
- Simplex Trading's Core Laboratories position peaked at $925K in Q3 2019.
- 191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.